Article Details
Retrieved on: 2024-07-01 16:43:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
- Humacyte, Inc. (NASDAQ:HUMA), a biotechnology firm, announced it has been awarded a third Regenerative Medicine Advanced Therapy (RMAT) designation ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here